This inventor holds 3 USPTO granted patents and 4 published patent applications. Top assignee: Biocytogen Pharmaceuticals (Beijing) Co., Ltd.. Active years: 2023-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2024
Title: **Huizhen Zhao: Pioneering Innovations in Genetically Modified Animals**
Introduction
Huizhen Zhao is a notable inventor based in Beijing, China, recognized for his contributions to the field of genetic engineering. With an impressive portfolio of three patents, Zhao focuses on creating novel genetically modified non-human animals that have significant implications for biomedical research and therapeutic applications.
Latest Patents
Among his latest innovations, Zhao holds patents for:
1. Genetically modified non-human animals with humanized immunoglobulin locus. This patent pertains to the development of genetically modified animals and cells equipped with a humanized heavy chain immunoglobulin locus and/or a humanized light chain immunoglobulin locus.
2. Genetically modified non-human animals with common light chain immunoglobulin locus. This invention describes genetically modified animals and cells featuring a humanized light chain immunoglobulin locus, along with a humanized heavy chain immunoglobulin locus. A key aspect of this innovation involves utilizing a limited number of human IGKV genes and human IGKJ genes within the endogenous light chain immunoglobulin locus.
Career Highlights
Huizhen Zhao is currently affiliated with Biocytogen Pharmaceuticals (Beijing) Co., Ltd., a leading company in the realm of biopharmaceuticals. His work focuses on advancing genetic engineering methodologies that can lead to new treatment avenues for various immunological diseases and conditions.
Collaborations
In his pursuit of innovative solutions, Zhao collaborates with esteemed colleagues such as Yuelei Shen and Jiawei Yao. These partnerships foster a rich collaborative environment that enhances the potential for groundbreaking discoveries within the company.
Conclusion
As an inventive force in the biotechnology sector, Huizhen Zhao is at the forefront of creating advanced genetically modified animals that promise to revolutionize our understanding of human health and disease management. His innovations not only contribute to the scientific community but also pave the way for future research that may lead to novel therapeutic strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile